Business Commons^™

Pharmaceutical Industry Analysis, External Environment, And Technological Assessment For The Development Of An Acquisition Strategy (Novavax), Jessica Freitas, Miluska Mogrovejo

Seaver College Research And Scholarly Achievement Symposium

At the end of 2012, Merck’s Net Sales totaled $47.27 B. The company’s Total Global Pharmaceutical Industry’s Share of Market (SOM) is about 4.3%, making it the seventh largest in the industry as of 2012. Merck’s biggest competitors include, Johnson & Johnson, Pfizer Inc., Novartis AG, Bayer AG, Roche Holding Ltd, and Sanofi. In order for Merck to maintain its U.S. and Global Market Share, sustain competitive advantage against its competitors, and maximize its Shareholder Wealth, it must assess its Environmental Threats and Opportunities. Merck greatest Threats are Competition, especially from generic products that devalue Merck’s brand drugs that lose …